Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Invasion and metastasis in cancer: molecular insights and therapeutic targets
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Leonardo Nicacio being referenced
723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
2021
SGNTV-001: Open label phase 2 study of tisotumab vedotin for locally advanced or metastatic disease in solid tumors.
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Leonardo Nicacio | 160 | 132 | 98 | 28 | 269 | |
| Antoine Angelergues | 73 | 129 | 65 | 30 | 193 | |
| Qingyu Wang | 115 | 72 | 58 | 43 | 242 | |
| Zhongmin Maxwell Wang | 191 | 63 | 53 | 17 | 287 | |
| J. Luna | 92 | 113 | 56 | 23 | 304 | |
| Oraianthi Fiste | 148 | 77 | 21 | 38 | 249 | |
| Durmuş Etiz | 115 | 185 | 85 | 28 | 319 | |
| V. Diéras | 257 | 63 | 37 | 25 | 317 | |
| Burçak Yılmaz | 91 | 161 | 94 | 29 | 286 | |
| Arzu Oğuz | 198 | 57 | 23 | 34 | 297 | |
| Andrea D’Aviero | 103 | 75 | 96 | 39 | 282 |
All Works
Loading papers...